InBody Co

InBody Co EBITDA per Share

The EBITDA per Share of InBody Co (041830.KQ) as of Oct 26, 2026 is 3,014.43 KRW. In the previous year, EBITDA per Share was 3,224.71 KRW — a change of -6.52% (lower).

EBITDA per Share

3,014.43KRW

YoY

-6.52%

Last updated:

EBITDA per Share of InBody Co is 2025 3,014.43 KRW. EBITDA per Share of InBody Co was 2024 3,224.71 KRW. It decreases by -6.52% lower compared to the previous year.

The InBody Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
1,842.93 KRW
Jan 1, 2019
2,298.03 KRW
Jan 1, 2020
1,740.00 KRW
Jan 1, 2021
3,015.92 KRW
Jan 1, 2022
3,426.74 KRW
Jan 1, 2023
3,277.01 KRW
Jan 1, 2024
3,224.71 KRW
Jan 1, 2025
3,014.43 KRW
The InBody Co EBITDA per Share history
YEAREBITDA per ShareYoY
3,014.43KRW-6.52%
3,224.71KRW-1.60%
3,277.01KRW-4.37%
3,426.74KRW+13.62%
3,015.92KRW+73.33%
1,740.00KRW-24.28%
2,298.03KRW+24.69%
1,842.93KRW-4.23%
1,924.34KRW+14.51%
1,680.51KRW+12.63%
1,492.11KRW+92.28%
776.01KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Stock analysis

What does InBody Co do? InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration. InBody Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBody Co stock

EBITDA per Share of InBody Co is 3,014.43 KRW in 2025.

EBITDA per Share of InBody Co changed from 3,224.71 KRW to 3,014.43 KRW, representing a -6.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share InBody Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — InBody Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — InBody Co